Nuclear aberrations in hair follicle cells of patients receiving cyclophosphamide
- 1 March 1990
- journal article
- research article
- Published by Springer Science and Business Media LLC in Archives of Toxicology
- Vol. 64 (2), 116-121
- https://doi.org/10.1007/bf01974396
Abstract
The toxic effect of cyclophosphamide on the proliferative cell population of hair follicles plucked from the human scalp was examined by the in vivo nuclear aberration assay. Patients participating in an independent clinical trial received oral low dose cyclophosphamide, intravenous high dose cyclophosphamide or oral placebo treatment. The percent of cells with nuclear aberrations (indicating apoptosis, a special form of cell death) and the percent of mitotic cells, in the hair matrix, were calculated for each patient before treatment and at several time points following cyclophosphamide or placebo treatment. The mean percentages of nuclear aberrations in both the treated Low dose and High dose cyclophosphamide patients were significantly higher than those for the pre-treatment and Placebo patients. The nuclear aberrations in hair follicle cells increased from pre-treatment (and Placebo) to treated Low dose and finally to treated High dose patients. The average percentage for pre-treatment samples from all patients was 0.06 ±0.03 SE. For 1 week and 1 month samples from Low dose patients it was 0.35 ±0.08 SE, and for combined 2,3 and 4 day samples from High dose patients it was 1.08 ±0.12 SE. Cyclophosphamide also had a significant effect on mitosis. A decrease in mitotic activity was observed at 1 month following the initial low dose cyclophosphamide treatment and at 24±2 h following each of the first two high dose cyclophosphamide treatments. The observed increase in nuclear aberrations following low dose as well as high dose cyclophosphamide suggests that it is feasible to use the nuclear aberration assay for in vivo human genotoxicity testing, using proliferating hair follicle cells.Keywords
This publication has 28 references indexed in Scilit:
- Nongenotoxicity of minoxidil in murine hair follicles as determined by the nuclear aberration assayToxicology and Applied Pharmacology, 1988
- Studies on the mechanism of action of diallyl sulfide, an inhibitor of the genotoxic effects of cyclophosphamideCanadian Journal of Physiology and Pharmacology, 1987
- Cyclophosphamide‐induced cytogenetic effects in mouse bone marrow and spleen cells in in vivo and in vivo/in vitro assaysTeratogenesis, Carcinogenesis, and Mutagenesis, 1987
- Cyclophosphamide: Interstrain differences in the production of mutagenic metabolites by S9-fractions from liver and kidney in different mutagenicity test systems in vitro and in the teratogenic response in vivo between CBA and C 57 BL miceTeratogenesis, Carcinogenesis, and Mutagenesis, 1987
- Quantitation of nuclear aberrations as a screen for agents damaging to mammary epitheliumCarcinogenesis: Integrative Cancer Research, 1986
- Cell Death (Apoptosis) in Hair Follicles and Consequent Changes in the Width of Hairs after Irradiation of Growing FolliclesInternational Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1985
- Comparison of the effects of 1,2-dimethylhydrazine and cyclophosphamide on micronucleus incidence in bone marrow and colonMutation Research, 1983
- Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activationNature, 1980
- Significance of the karyorrhectic index in 1,2-dimethylhydrazine carcinogenesisCancer Letters, 1979
- Hydroxylation of dehydroepiandrosterone in human scalp hair folhclesBritish Journal of Dermatology, 1979